These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacokinetics in the elderly. Crooks J; O'Malley K; Stevenson IH Clin Pharmacokinet; 1976; 1(4):280-96. PubMed ID: 797500 [TBL] [Abstract][Full Text] [Related]
4. Hepatic drug metabolism in cystic fibrosis: recent developments and future directions. Kearns GL Ann Pharmacother; 1993 Jan; 27(1):74-9. PubMed ID: 8431626 [TBL] [Abstract][Full Text] [Related]
5. Age-related changes in liver size and hepatic blood flow. The influence on drug metabolism in the elderly. Woodhouse KW; Wynne HA Clin Pharmacokinet; 1988 Nov; 15(5):287-94. PubMed ID: 3203484 [TBL] [Abstract][Full Text] [Related]
6. Drug control of steroid metabolism by the hepatic endoplasmic reticulum. Feuer G Drug Metab Rev; 1983; 14(6):1119-44. PubMed ID: 6373207 [TBL] [Abstract][Full Text] [Related]
8. The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. Le Couteur DG; McLean AJ Clin Pharmacokinet; 1998 May; 34(5):359-73. PubMed ID: 9592620 [TBL] [Abstract][Full Text] [Related]
10. Biotransformation of drugs during aging. Kiechel JR Gerontology; 1982; 28 Suppl 1():101-12. PubMed ID: 7044902 [TBL] [Abstract][Full Text] [Related]
11. Age-related changes in hepatic function. Implications for drug therapy. Woodhouse K; Wynne HA Drugs Aging; 1992; 2(3):243-55. PubMed ID: 1606355 [TBL] [Abstract][Full Text] [Related]
12. The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in children. Johnson TN Toxicology; 2003 Oct; 192(1):37-48. PubMed ID: 14511902 [TBL] [Abstract][Full Text] [Related]
13. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity. Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371 [TBL] [Abstract][Full Text] [Related]
14. Hepatic drug metabolism and ageing. Woodhouse KW; James OF Br Med Bull; 1990 Jan; 46(1):22-35. PubMed ID: 2405943 [TBL] [Abstract][Full Text] [Related]
15. [Changes in pharmacokinetics in elderly patients]. Nadai M; Katoh M Nihon Rinsho; 2013 Jun; 71(6):999-1003. PubMed ID: 23855202 [TBL] [Abstract][Full Text] [Related]
16. Drug therapy in the elderly. Williams L; Lowenthal DT South Med J; 1992 Feb; 85(2):127-31. PubMed ID: 1738877 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic changes in the elderly. Do they contribute to drug abuse and dependence? Ozdemir V; Fourie J; Busto U; Naranjo CA Clin Pharmacokinet; 1996 Nov; 31(5):372-85. PubMed ID: 9118585 [TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic basis for altered drug action in the elderly. Roberts J; Tumer N Clin Geriatr Med; 1988 Feb; 4(1):127-49. PubMed ID: 3278786 [TBL] [Abstract][Full Text] [Related]
19. [The effect of changes in nutritional status induced by age on oxidative liver metabolism]. Jorquera Plaza F; Cuevas González MJ; Pozuelo Manchón M; San Segundo D; Almar Galiana M; González Sastre M; González-Gallego J Nutr Hosp; 1997; 12(3):134-40. PubMed ID: 9617173 [TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update. Morgan DJ; McLean AJ Clin Pharmacokinet; 1995 Nov; 29(5):370-91. PubMed ID: 8582120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]